Page 41 - 《中国药房》2022年21期
P. 41

发。现阶段,该领域相关研究多集中于中药有效成分与                           [ 8 ]  ZHUO Y Q,YUAN R,CHEN X X,et al. Tanshinone I
          中成药的干预机制研究,研究热点多为细胞凋亡、细胞                                exerts cardiovascular protective effects in vivo and in vitro
          焦亡、线粒体功能障碍或miRNA与MIRI之间的联系以                             through inhibiting necroptosis via Akt/Nrf2 signaling path‐
          及相关信号通路的调控,预测未来的研究也会围绕于此                                way[J]. Chin Med,2021,16(1):48.
                                                             [ 9 ]  JIANG L J,YIN X J,CHEN Y H,et al. Proteomic analy‐
          开展。此外,中药防治 MIRI 的科研在现阶段多集中于
                                                                  sis reveals ginsenoside Rb1 attenuates myocardial ischemia/
          基础实验领域,建议未来多开展大规模、高质量、多中
                                                                  reperfusion injury through inhibiting ROS production
          心、随机对照的临床研究,以期为中药应用于临床提供
                                                                  from mitochondrial complex Ⅰ[J]. Theranostics,2021,11
          高级别循证医学证据。总之,本研究的分析结果揭示了
                                                                 (4):1703-1720.
          中医药防治MIRI的研究现状、热点及趋势,并罗列出目
                                                             [10]  LI L,PAN C S,YAN L,et al. Ginsenoside Rg1 ameliorates
          前研究较多的药物的具体应用情况,可为研究者在该领
                                                                  rat myocardial ischemia-reperfusion injury by modulating
          域深入探索提供参考与借鉴。                                           energy metabolism pathways[J]. Front Physiol,2018,9:78.
          参考文献                                               [11]  LI L,WANG Y L,GUO R,et al. Ginsenoside Rg3-loaded,
          [ 1 ]  MEIER T,GRÄFE K,SENN F,et al. Cardiovascular mor‐  reactive oxygen species-responsive polymeric nanopar‐
              tality attributable to dietary risk factors in 51 countries in  ticles for alleviating myocardial ischemia-reperfusion
              the WHO European Region from 1990 to 2016:a syste-  injury[J]. J Control Release,2020,317:259-272.
              matic analysis of the global burden of disease study[J].  [12]  XUE Y,FU W W,LIU Y Z,et al. Ginsenoside Rb2 alle-
              Eur J Epidemiol,2019,34(1):37-55.                   viates myocardial ischemia/reperfusion injury in rats
          [ 2 ]  HEUSCH G. Myocardial ischaemia-reperfusion injury  through SIRT1 activation[J]. J Food Sci,2020,85(11):
              and cardioprotection in perspective[J]. Nat Rev Cardiol,  4039-4049.
              2020,17(12):773-789.                           [13]  YIN B,HOU X W,LU M L. Astragaloside Ⅳ attenuates
          [ 3 ]  HAUSENLOY D J,KHARBANDA R K,MØLLER U K,          myocardial ischemia/reperfusion injury in rats via inhibi‐
              et al. Effect of remote ischaemic conditioning on clinical  tion of calcium-sensing receptor-mediated apoptotic sig‐
              outcomes in patients with acute myocardial infarction  naling pathways[J]. Acta Pharmacol Sin,2019,40(5):
              (CONDI-2/ERIC-PPCI):a single-blind randomised con‐  599-607.
              trolled trial[J]. Lancet,2019,394(10207):1415-1424.  [14]  YU L M,LI Z,DONG X,et al. Polydatin protects diabetic
          [ 4 ]  岳栋芳,李永芳 . 中药及其复方抗心肌缺血再灌注损伤                       heart against ischemia-reperfusion injury via Notch1/
              的作用机制研究进展[J/OL].中药药理与临床,2022:1-25                   Hes1-mediated activation of pten/Akt signaling[J]. Oxid
              [2022-10-19]. https://kns.cnki.net/kcms/detail/detail.aspx?  Med Cell Longev,2018,2018:2750695.
              dbcode=CAPJ&dbname=CAPJLAST&filename=ZYYL-     [15]  HU Y J,PAN H W,PENG J Q,et al. Resveratrol inhibits
              20220311000&uniplatform=NZKPT&v=g3PdBwCvGt-         necroptosis by mediating the TNF- α/RIP1/RIP3/MLKL
              CRvqgc-7x52COLo55F5YCBHn8k4U0PTWIdJdgYLX-           pathway in myocardial hypoxia/reoxygenation injury[J].
              N5ct0aGLjbSUs5.DOI:10.13412/j.cnki.zyyl.20220313.003.  Acta Biochim Biophys Sin(Shanghai),2021,53(4):
          [ 5 ]  MA D,YANG B,GUAN B Y,et al. A bibliometric analy‐  430-437.
              sis of pyroptosis from 2001 to 2021[J]. Front Immunol,  [16]  ZHAO G L,YU L M,GAO W L,et al. Berberine protects
              2021,12:731933.                                     rat heart from ischemia/reperfusion injury via activating
          [ 6 ]  祁祥,卢健棋,朱智德,等.近10年经方真武汤的文献计                       JAK2/STAT3 signaling and attenuating endoplasmic re‐
              量学研究与可视化分析[J/OL]. 中国现代中药,2022:1-                    ticulum stress[J]. Acta Pharmacol Sin,2016,37(3):
              14[2022-09-04]. https://kns.cnki.net/kcms/detail/detail.  354-367.
              aspx? dbcode=CAPJ&dbname=CAPJLAST&filename=    [17]  JIN Z,GAN C,LUO G,et al. Notoginsenoside R1 protects
              YJXX20220126001&uniplatform=NZKPT&v=GhfZ‐           hypoxia-reoxygenation deprivation-induced injury by
              blymhfFgbpjnxjRHK1Si4Vu1Evty0PgolzqEsRP9x7nkQr      upregulation of miR-132 in H9c2 cells[J]. Hum Exp
              AtKdhQX-JUD0W3. DOI:10.13313/j. issn. 1673-4890.    Toxicol,2021,40(12_suppl):S29-S38.
              20211014001.                                   [18]  CHANG X Y,ZHANG K,ZHOU R,et al. Cardioprotec‐
          [ 7 ]  LI Q,SHEN L,WANG Z,et al. Tanshinone ⅡA protects  tive effects of salidroside on myocardial ischemia-
              against myocardial ischemia reperfusion injury by activa-  reperfusion injury in coronary artery occlusion-induced
              ting the PI3K/Akt/mTOR signaling pathway[J]. Biome-  rats and Langendorff-perfused rat hearts[J]. Int J Cardiol,
              decine Pharmacother,2016,84:106-114.                2016,215:532-544.


          中国药房    2022年第33卷第21期                                            China Pharmacy 2022 Vol. 33 No. 21  ·2595·
   36   37   38   39   40   41   42   43   44   45   46